中枢血清性胆色素变异症的药理学关联:超越皮质类固醇
Manish Jain1, Arthi Mohankumar2, Jairo Torres3
1Al Dhannah Hospital, Western Region, Abu Dhabi, United Arab Emirates.
Survey of ophthalmology
|February 11, 2025
概括
中央血清性胆色素变异症 (CSCR) 与各种因素有关,包括药物. 审查药物史对于识别可修改的风险在特异性CSCR病例至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 中央血清性胆色素变异症 (CSCR) 与心理压力,皮质类固醇和某些性格特征有关.
- 其他涉及的药物包括交感模拟剂,精神药物和固酶抑制剂.
- 荷尔蒙的影响是由男性占优势和更高的发病率在怀孕/绝经妇女建议.
研究的目的:
- 审查与中央血清性胆色素变异症 (CSCR) 相关的药物.
- 探索将毒品使用与CSCR联系在一起的潜在机制.
- 强调药物病史在治疗异常性CSCR方面的重要性.
主要方法:
- 关于在CSCR中涉及的药物的综合文献审查.
- 对药物机制和不良事件概况的分析.
- 检查全身和胆道血液动力学变化.
主要成果:
- 审查了各种各样的药物,包括交感模拟剂,精神药物,固酶抑制剂,淋巴腺激素,血管压素,米诺克西迪尔和其他药物.
- 机制包括下丘脑-垂体-上腺轴的改变,交感神经系统的激活,以及氧化合成酶的变化.
- 系统性和胆道性血液动力学变化似乎是一个共同点.
结论:
- 药物代表了中央血清性胆色素变异症 (CSCR) 的重要,往往被忽视的风险因素.
- 了解药物诱导的机制是管理CSCR的关键.
- 详细的药物病史,包括影响细胞染色体P450-3A4的药物,对于确定异常性CSCR中可修改的风险至关重要.
相关概念视频
01:27Open Angle Glaucoma: Treatment
386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
386
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
673
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
673
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
608
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
608